Andrew
Analyst
Jeffries
Equibles does not estimate personal net worth.
About Andrew
Andrew is recorded as Analyst at Jeffries. Andrew has spoken on 2 earnings calls across 2 companies, most recently for BridgeBio Pharma, Inc. on August 10, 2026. Those appearances were for BridgeBio Pharma, Inc. (BBIO) and Enterprise Products Partners L.P. (EPD). The companies whose calls Andrew spoke on are classified in the Healthcare and Energy sectors.
Andrew on recent calls
“So I think this was a quarter where all three of your pipeline programs moved from the clinic into the regulatory phases. You got LGMD submitted within five months of the top line, two prior reviews, no ad comms planned.”
“Just two quick questions from my friend. The first one being we're seeing a sequentially stronger quarter in crude, I think both from a volumetric and a per barrel margin standpoint.”
Affiliation history
-
Jeffries
Analyst
Transcript header (unverified)
Current